Diabetes mellitus is one of the major health concerns worldwide affecting 425 million people and its prevalence is expected to increase to 629 million by 2045. It is estimated that 12% of the global health expenditure is spent on diabetes (around $727 billion). One serious complication of diabetes mellitus is the diabetic foot ulcer (DFU). Impaired local blood circulation and the resulting low tissue oxygenation, nutrient supply and waste elimination is a major cause for compromised wound healing in diabetic patients and wounds often become chronic and non-healing.

According to the UN, it is expected that by 2050, 70% of the world’s population will live in cities. This implies an increase in both individual travel and traffic congestion. There is an urgent demand for “Smart Cities” replacing the fossil-fuel vehicles by public transport and sharing systems, actively promoting an environmentally-friendly and sustainable form of transportation.

An international research facility based in Switzerland is looking for companies able to manufacture cold bore tubes. The research centre's first goal is to study particles interaction.

Established in 2016 in Switzerland, the innovative company is active in the healthcare sector and mainly focused on dermatology and personal care. Its core business is to provide consumers and customers with an increased choice of high performance tailor made products. An extensive focus is put on segments currently under served where there is a high need of meaningful consumer and customer centric innovation. To ensure highest quality and safety standards of their products, the company works exclusively with selected partners with cutting edge innovation, R&D and production capabilities.